CN111662246A
|
|
Mirabegron impurity compound and preparation method and application thereof
|
CN111518152A
|
|
Preparation method and application of 3 alpha, 7 alpha-dihydroxy-6 alpha-ethyl-5 beta-cholane-24-aldehyde
|
CN111333633A
|
|
Rugosril intermediate compound and preparation method and application thereof
|
CN111423452A
|
|
Rugoside intermediate, preparation method and application thereof
|
CN111303234A
|
|
Abiraterone acetate monocrystal and preparation method thereof
|
CN111320552A
|
|
Preparation method of enzalutamide intermediate
|
CN111253461A
|
|
Synthesis method of 7-oxoacetic acid abiraterone
|
CN109535107A
|
|
One kind (R) -4- propyl-dihydrofuran -2- ketone preparation method
|
CN109574778A
|
|
A kind of preparation method of Bu Waxitan and its intermediate
|
CN109613174A
|
|
A kind of detection method of quassia total alkaloid content
|
CN107973764A
|
|
Andrographolide class compound, its preparation method, pharmaceutical composition and application
|
CN107648245A
|
|
Application of the neohesperidin in prevention and treatment senile dementia is prepared
|
CN107693530A
|
|
Aurantiamarin and/or aurantiin are preparing the application in improving cognition dysfunction medicine
|
CN107569477A
|
|
The new application of ethyl sulfuric acid class compound
|
CN109394746A
|
|
Ethyl sulfuric acid ammonium is in preparation for preventing or treating the application in diseases associated with inflammation drug
|
CN109381453A
|
|
Potassium ethyl sulfate is in preparation for preventing or treating the application in diseases associated with inflammation drug
|
CN109381452A
|
|
Application of ethyl sulfuric acid class compound and preparation method thereof
|
CN108392478A
|
|
Application of the andrographolide class compound in terms of preparing for radioactive damage drug
|
CN107375271A
|
|
Application of the andrographolide sulfonate/derivative/mixture in treatment/prevention of neurodegenerative diseases medicine is prepared
|
CN107375272A
|
|
Application of the Camptotheca acuminata leaves in treatment and/or prevention of neurodegenerative diseases medicine is prepared
|